Achieve Therapeutic Localization with Selective, Effective & Validated Delivery to Intracellular Targets

Optimize Your Pipeline’s Therapeutic Index with Novel Delivery Systems to Overcome Endosomal Barriers in Target Cells

Selective cell entry, biological barriers and complexities in targeting chemistry have long restricted the ability of promising drug candidates to impactfully engage their intracellular sites of action without off-target toxicity implications.

Fast forward to 2023, advances in nanomedicine technology, the LNP enabled mRNA vaccine and emphasis on personalized medicine has triggered significant pipeline shifts towards complex nucleic-acid and biologic candidates. This clinical translation depends on novel delivery systems accessing previously elusive intracellular compartments. This is further evidenced by AstraZeneca, Boehringer Ingelheim and Eli Lilly’s announcements of prioritized strategic investment in targeted intracellular delivery technologies.

At such a pivotal moment for the industry, the Targeted Intracellular Delivery Summit arrives to bring Formulation, Chemistry, Delivery & Biology industry professionals to the forefront of cutting-edge science critical to accelerate pharmaceutical R&D. Join 80+ senior leaders to explore target identification, tissue delivery, engineering technologies, endosomal escape, delivery validation analytics and more.

This is your definitive meeting for unpresented data, unrivalled insights and unmissable methodologies across the next-generation nano-platforms including LNPs, EVs, Liposomes & more, creating new opportunities for the development of safer and efficacious oligonucleotide, siRNA, mRNA, DNA delivery and protein payloads.

Unleash the true potential of your pipeline by gaining the best picture of industry’s fast-paced nano-platform progress this March!

To know more visit: https://ter.li/i23a5q